Urinary tuberculosis is associated with the development of urothelial carcinoma but not renal cell carcinoma: A nationwide cohort study in Taiwan

British Journal of Cancer

Volumn 109, Issue 11, 2013, Pages 2933-2940

  Lien, Y C ^a   Wang, J Y ^b   Lee, M C ^a   Shu, C C ^b   Chen, H Y ^a   Hsieh, C H ^c,d   Lee, C H ^a,d   Lee, L N ^b   Chao, K M ^e  

^a TAIPEI TZU CHI HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c Taipei Tzu Chi Medical University Hospital   (Taiwan)

^d TZU CHI UNIVERSITY   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Cohort study; National Health Insurance Research Database; Obstructive uropathy; Taiwan; Tuberculosis; Urinary tract cancer

Indexed keywords

AMINOSALICYLIC ACID; CYCLOSERINE; ETHAMBUTOL; ISONIAZID; KANAMYCIN; PROTIONAMIDE; PYRAZINAMIDE; QUINOLONE DERIVATIVE; RIFAMPICIN; STREPTOMYCIN; TERIZIDONE;

ADULT; ARSENIC POISONING; ARTICLE; CANCER INCIDENCE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HAZARD RATIO; HEALTH INSURANCE; HUMAN; KIDNEY CARCINOMA; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; OBSTRUCTIVE UROPATHY; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; TAIWAN; TRANSITIONAL CELL CARCINOMA; URINARY TRACT CANCER; UROGENITAL TUBERCULOSIS;

ADULT; AGED; CARCINOMA, RENAL CELL; CARCINOMA, TRANSITIONAL CELL; COHORT STUDIES; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; TAIWAN; TUBERCULOSIS, UROGENITAL; URINARY TRACT INFECTIONS; UROLOGIC NEOPLASMS; UROTHELIUM;

EID: 84888870069     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.538     Document Type: Article

References (48)

1. Alexiev BA, Randhawa P, Vazquez Martul E, Zeng G, Luo C, Ramos E, Drachenberg CB, Papadimitriou JC (2013) BK virus-associated urinary bladder carcinoma in transplant recipients: report of 2 cases, review of the literature, and proposed pathogenetic model. Hum Pathol 44(5): 908-917.
2. Ardalan MR, Shoja MM (2008) Radiological findings in renal tuberculosis: a report from northwest of Iran. Saudi J Kidney Dis Transplantat 19(1): 76-79.
3. Bevers RF, Kurth KH, Schamhart DH (2004) Role of urothelial cells in BCG immunotherapy for superficial bladder cancer. Br J Cancer 91(4): 607-612. (Pubitemid 39141611)
4. Blanc L, Falzon D, Fitzpatrick C, Floyd K, Garcia I, Gilpin C, Glaziou P, Hiatt T, Sculier D, Sismanidis C, Timimi H, Uplekar M (2010) Global Tuberculosis Control 2010. World Health Organization: Geneva, Switzerland.
5. Bureau of Health Promotion, Department of Health (2009) Cancer registry annual report: Cancer Control and Prevention Division. Bureau of Health Promotion, Department of Health: Taiwan, Republic of China.
6. Chang CH, Shau WY, Jiang YD, Li HY, Chang TJ, Sheu WH, Kwok CF, Ho LT, Chuang LM (2010a) Type 2 diabetes prevalence and incidence among adults in Taiwan during 1999-2004: a national health insurance data set study. Diabet Med 27(6): 636-643.
7. Chang FY, Shi WY, Lin T, Chou JH, Chen YH, Chuang JH, Yang CH, Yang SL, Lo HY, Lee CY, Wang KF, Chang PC (2010b) Taiwan Tuberculosis Control Report 2010. Centers for Disease Control, Department of Health, R.O.C (Taiwan): Taipei.
8. Chou YH, Huang CH (1999) Unusual clinical presentation of upper urothelial carcinoma in Taiwan. Cancer 85(6): 1342-1344.
9. Chow WH, Gridley G, Fraumeni Jr JF, Jarvholm B (2000) Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med 343(18): 1305-1311.
10. Chow WH, Lindblad P, Gridley G, Nyren O, McLaughlin JK, Linet MS, Pennello GA, Adami HO, Fraumeni Jr JF (1997) Risk of urinary tract cancers following kidney or ureter stones. J Natl Cancer Inst 89(19): 1453-1457. (Pubitemid 27419209)
11. De Ridder D, van Poppel H, Demonty L, D'Hooghe B, Gonsette R, Carton H, Baert L (1998) Bladder cancer in patients with multiple sclerosis treated with cyclophosphamide. J Urol 159(6): 1881-1884. (Pubitemid 29190717)
12. Dou H-Y, Huang S-C, Su I-J (2011) Prevalence of mycobacterium tuberculosis in Taiwan: a model for strain evolution linked to population migration. Int J Evol Biol 2011: doi:10.4061/2011/937434.
13. Elkington P, Shiomi T, Breen R, Nuttall RK, Ugarte-Gil CA, Walker NF, Saraiva L, Pedersen B, Mauri F, Lipman M, Edwards DR, Robertson BD, D'Armiento J, Friedland JS (2011) MMP-1 drives immunopathology in human tuberculosis and transgenic mice. J Clin Investig 121(5): 1827-1833.
14. Hecht SS (2006) Cigarette smoking: cancer risks, carcinogens, and mechanisms. Langenbecks Arch Surg 391(6): 603-613. (Pubitemid 44657742)
15. Howlader NNA, Krapcho M, Garshell J, Neyman N, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds) (2013) SEER Cancer Statistics Review 1975-2010. National Cancer Institute: Besthesda, MD, USA.
16. Hurst FP, Jindal RM, Fletcher JJ, Dharnidharka V, Gorman G, Lechner B, Nee R, Agodoa LY, Abbott KC (2011) Incidence, predictors and associated outcomes of renal cell carcinoma in long-term dialysis patients. Urology 77(6): 1271-1276.
17. Johansson SL, Cohen SM (1997) Epidemiology and etiology of bladder cancer. Semin Surg Oncol 13(5): 291-298. (Pubitemid 27332851)
18. Jung KW, Park S, Shin A, Oh CM, Kong HJ, Jun JK, Won YJ (2012) Do female cancer patients display better survival rates compared with males? Analysis of the Korean National Registry data, 2005-2009. PLoS One 7(12): e52457.
19. Kakehi Y, Hirao Y, Kim WJ, Ozono S, Masumori N, Miyanaga N, Nasu Y, Yokomizo A (2010) Bladder Cancer Working Group report. Jpn J Clin Oncol 40(Suppl 1): i57-i64.
20. Kantor AF, Hartge P, Hoover RN, Narayana AS, Sullivan JW, Fraumeni Jr JF (1984) Urinary tract infection and risk of bladder cancer. Am J Epidemiol 119(4): 510-515. (Pubitemid 14134659)
21. Lai MN, Lai JN, Chen PC, Hsieh SC, Hu FC, Wang JD (2010a) Risks of kidney failure associated with consumption of herbal products containing Mu Tong or Fangchi: a population-based case-control study. Am J Kidney Dis 55(3): 507-518.
22. Lai MN, Wang SM, Chen PC, Chen YY, Wang JD (2010b) Population-based case-control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk. J Natl Cancer Inst 102(3): 179-186.
23. Lawn SD, Afful B, Acheampong JW (1998) Pulmonary tuberculosis: diagnostic delay in Ghanaian adults. Int J Tuberc Lung Dis 2(8): 635-640. (Pubitemid 28383855)
24. Lee CH, Lee MC, Lin HH, Shu CC, Wang JY, Lee LN, Chao KM (2012) Pulmonary tuberculosis and delay in anti-tuberculous treatment are important risk factors for chronic obstructive pulmonary disease. PLoS One 7(5): e37978.
25. Lee CH, Lee MC, Shu CC, Lim CS, Wang JY, Lee LN, Chao KM (2013) Risk factors for pulmonary tuberculosis in patients with chronic obstructive airway disease in Taiwan: a nationwide cohort study. BMC Infect Dis 13(1): 194.
26. Lin HH, Ezzati M, Chang HY, Murray M (2009) Association between tobacco smoking and active tuberculosis in Taiwan: prospective cohort study. Am J Respir Crit Care Med 180(5): 475-480.
27. Ling S, Chang X, Schultz L, Lee TK, Chaux A, Marchionni L, Netto GJ, Sidransky D, Berman DM (2011) An EGFR-ERK-SOX9 signaling cascade links urothelial development and regeneration to cancer. Cancer Res 71(11): 3812-3821.
28. Ljungberg B, Campbell SC, Choi HY, Jacqmin D, Lee JE, Weikert S, Kiemeney LA (2011) The epidemiology of renal cell carcinoma. Eur Urol 60(4): 615-621.
29. Luh K-T (ed.) (2011) Taiwan Guidelines for TB Diagnosis and Treatment. Centers for Disease Control, R.O.C. (Taiwan): Taipei, Taiwan.
30. Lynch CF, Cohen MB (1995) Urinary system. Cancer 75(Suppl 1): 316-329.
31. Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB, Wolfe RA, Jones E, Disney AP, Briggs D, McCredie M, Boyle P (1999) Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 354(9173): 93-99. (Pubitemid 29313142)
32. Mamtani R, Haynes K, Bilker WB, Vaughn DJ, Strom BL, Glanz K, Lewis JD (2012) Association between longer therapy with thiazolidinediones and risk of bladder cancer: a cohort study. J Natl Cancer Inst 104(18): 1411-1421.
33. Mitropoulos DN (2005) Novel insights into the mechanism of action of intravesical immunomodulators. In Vivo 19(3): 611-621.
34. Mungan NA, Aben KK, Schoenberg MP, Visser O, Coebergh JW, Witjes JA, Kiemeney LA (2000) Gender differences in stage-adjusted bladder cancer survival. Urology 55(6): 876-880. (Pubitemid 30330791)
35. Noon AP, Albertsen PC, Thomas F, Rosario DJ, Catto JW (2013) Competing mortality in patients diagnosed with bladder cancer: evidence of undertreatment in the elderly and female patients. Br J Cancer 108(7): 1534-1540.
36. Ploeg M, Aben KK, Kiemeney LA (2009) The present and future burden of urinary bladder cancer in the world. World J Urol 27(3): 289-293.
37. Pommer W, Bronder E, Klimpel A, Helmert U, Greiser E, Molzahn M (1999) Urothelial cancer at different tumour sites: role of smoking and habitual intake of analgesics and laxatives. Results of the Berlin Urothelial Cancer Study. Nephrol Dial Transplant 14(12): 2892-2897.
38. Public Assistance Act (2010) Taipei, Taiwan (R.O.C): Ministry of the Interior.
39. Schoppmann SF, Birner P, Stockl J, Kalt R, Ullrich R, Caucig C, Kriehuber E, Nagy K, Alitalo K, Kerjaschki D (2002) Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol 161(3): 947-956. (Pubitemid 34988382)
40. Scosyrev E, Noyes K, Feng C, Messing E (2009) Sex and racial differences in bladder cancer presentation and mortality in the US. Cancer 115(1): 68-74.
41. Siegel R, Ward E, Brawley O, Jemal A (2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61(4): 212-236.
42. Steen TW, Mazonde GN (1998) Pulmonary tuberculosis in Kweneng District, Botswana: delays in diagnosis in 212 smear-positive patients. Int J Tuberc Lung Dis 2(8): 627-634. (Pubitemid 28383854)
43. Tseng WP (1989) Blackfoot disease in Taiwan: a 30-year follow-up study. Angiology 40(6): 547-558.
44. Vamvakas S, Bahner U, Heidland A (1997) Increased cancer incidence in terminal kidney failure: potential pathogenetic mechanisms. Schweiz Med Wochenschr 127(14): 597-604. (Pubitemid 27181755)
45. Viart L, Surga N, Collon S, Jaureguy M, Elalouf V, Tillou X (2013) The high rate of de novo graft carcinomas in renal transplant recipients. Am J Nephrol 37(2): 91-96.
46. Wen CP, Levy DT, Cheng TY, Hsu CC, Tsai SP (2005) Smoking behaviour in Taiwan, 2001. Tob Control 14(Suppl 1): i51-i55. (Pubitemid 40806905)
47. WHO International Working Group for Drug Statistics Methodology (2011) Guidelines for ATC classification and DDD assignment. WHO Collaborating Centre for Drug Statistics Methodology: Oslo, Norway.
48. Wise GJ, Marella VK (2003) Genitourinary manifestations of tuberculosis. Urol Clin North Am 30(1): 111-121. (Pubitemid 36158474)